Find clinical trials for Melanoma in Taipei City
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Melanoma trials near Taipei City, TWN:
(PK) similarity and efficacy, safety, and immunogenicity of ABP 206 compared with OPDIVO® (nivolumab) in subjects with resected advanced melanoma...
Phase 3
Taipei, Taiwan and 110 other locations
assess the efficacy, safety, and immunogenicity of ABP 206 compared with Nivolumab in Subjects with Treatment-Naïve Unresectable or Metastatic Melanoma...
Phase 3
Taipei, Taiwan and 184 other locations
is safe and prevents cancer from returning in people with high-risk melanoma. Researchers want to know if intismeran autogene with pembroliz...
Phase 3
Taipei, Taiwan and 165 other locations
in combination with Yervoy-EU (induction phase only), in participants with advanced (unresectable Stage III or metastatic Stage IV) melanoma....
Phase 3
Taoyuan City, Taiwan and 49 other locations
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of KIN-2787 in adults with BRAF/NR...
Phase 1
Taipei, Taiwan and 30 other locations
and DKY709 in combination with PDR001 in subjects with NSCLC or melanoma who have received prior anti-PD-1/PD-L1 therapy, or subjects with N...
Phase 1
Taipei, Taiwan and 8 other locations
The purpose of this first in human (FIH) trial is to characterize the safety and tolerability of the SHP2 inhibitor TNO155 alone and in combination w...
Phase 1
Taipei, Taiwan and 17 other locations
A Phase II, Multicenter, Open-Label Trial of DB-1311 in combination with BNT327 or DB-1305 in Participants with Advanced/Metastatic Solid Tumors
Phase 2
Taipei City, Taipei, Taiwan and 14 other locations
solid tumors. The study is enrolling cohorts of participants with melanoma \[cutaneous/acral\], squamous cell carcinomas of the head and nec...
Phase 2
Taipei, Taiwan and 61 other locations
The purpose of this study is to characterize the safety and tolerability of KFA115 and KFA115 in combination with pembrolizumab in patients with sele...
Phase 1
Taipei, Taiwan and 16 other locations
Clinical trials
Research sites
Resources
Legal